Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:15 PM
Ignite Modification Date:
2026-03-26 @ 3:15 PM
NCT ID:
NCT07351266
Eligibility Criteria:
Inclusion Criteria:
* Histologically confirmed renal cell carcinoma with regional lymph node metastasis.
* Primary tumor with a maximum diameter ≥ 7 cm.
* Tumor exhibits a multinodular distribution pattern on cross-section (assessed via intraoperative or postoperative gross specimen).
* Age \> 18 years.
* Ability to understand the study and voluntarily provide written informed consent.
Exclusion Criteria:
* Presence of distant metastasis (M1 stage).
* Prior receipt of any targeted therapy or immunotherapy for renal cell carcinoma before surgery.
* History of other active malignancies besides RCC (except cured basal cell carcinoma of the skin or carcinoma in situ of the cervix).
* Any psychiatric, neurological, or legal condition that may compromise the ability to understand the informed consent or to comply with study procedures.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07351266
Study Brief:
Protocol Section:
NCT07351266